Biomea Fusion, Inc. presented patient cohorts in COVALENT-111 showing a reduction in HbA1c while off therapy at week 26, supporting improved pancreatic function.
AI Assistant
BIOMEA FUSION INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.